Exploration of New Treatment in Advanced Pancreatic Cancer
博士 === 國立臺灣大學 === 臨床醫學研究所 === 107 === Pancreatic cancer is highly lethal with great medical unmet needs. The majority of patients have adenocarcinoma. The 5-year overall survival (OS) rate is 5%. At initial diagnosis, only 20% of patients have resectable diseases. Gemcitabine and 5-FU/5-FU analogs a...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2019
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/3tf46y |